Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.23.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Equtiy Compensation Plan by Arrangements

The following table contains information about the Company’s stock plan at September 30, 2023:

 

  Awards
Reserved for
Issuance
    Awards
Issued &
Exercised
    Awards
Available
for Grant
 
2013 Equity Compensation Plan     54,294 *     37,915 **     16,379  

 

* Increased by 8,691 on January 1, 2023, representing 4% of the total number of shares of common stock outstanding on December 31, 2022.
** Includes both restricted stock grants and option grants
Schedule of Recognized Stock Based Compensation

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows:

 

   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
    2023     2022     2023     2022  
Research and Development   $ 507     $ 554     $ 1,576     $ 1,660  
General and Administrative     689       859       2,100       2,228  
Total   $ 1,196     $ 1,413     $ 3,676     $ 3,888  
Schedule of Stock Option Activity

The following table summarizes the activity for Company’ stock options for the nine months ended September 30, 2023:

 

    Stock Options  
Outstanding at December 31, 2022     34,739  
Granted     105  
Exercised      
Forfeited     (296 )
Expired     (1,314 )
Outstanding at September 30, 2023     33,234